PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1352 (108th)

Biomedical Research Assistance Voluntary Option Act

referredUnited States· United States Congress· EN

Introduced

19 March 2003

Last action

10 April 2003 · Referred

Status

Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.

Sponsors

Rep. Bilirakis, Michael [R-FL-9]

Subjects

Taxation

Source updated

18 August 2025

Taxation

Summary

Biomedical Research Assistance Voluntary Option Act - Amends the Internal Revenue Code to allow a taxpayer to designate any income tax overpayment to be used for biomedical research conducted through the National Institutes of Health.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 19 March 2003

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 19 March 2003

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 19 March 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 19 March 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 10 April 2003

    Referred

    Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.